All In Biotech

Free tool

FAERS Monitor: Besponsa

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761040 or its brand name (Besponsa, Inotuzumab Ozogamicin). Reports on generic versions are filed under their own applications.

Reports

2,992

Serious

2,854

95% of reports

Hospitalization

1,193

Death reported

1,018

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death360
  • febrile neutropenia267
  • venoocclusive liver disease260
  • off label use232
  • pyrexia198
  • neoplasm progression155
  • thrombocytopenia154
  • acute lymphocytic leukaemia recurrent148
  • drug ineffective143
  • cytokine release syndrome142
  • sepsis138
  • venoocclusive disease132
  • neutropenia122
  • platelet count decreased121
  • infection96

Reports by year received

View as table
YearReports
20071
20085
20094
201013
201113
201229
201329
201464
201571
201678
201777
2018245
2019251
2020255
2021368
2022365
2023350
2024343
2025254
2026177

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,167 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute lymphocytic leukaemia recurrentSignal148427.6363.758,991
venoocclusive diseaseSignal132391.2329.548,306
venoocclusive liver diseaseSignal260390.6346.695,383
cytokine release syndromeSignal14250.142.76,744
neoplasm progressionSignal15531.527.04,531
febrile neutropeniaSignal26728.425.37,026
thrombocytopeniaSignal1549.78.31,197
sepsisSignal1388.77.4937
platelet count decreasedSignal1218.06.7736
neutropeniaSignal1226.35.3543
infectionSignal964.73.8274
pyrexiaSignal1984.03.5454
deathSignal3602.92.7478
off label use2321.91.696
drug ineffective1430.80.611

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.